Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA03 - Predicting Outcomes in Patients with Early Disease NSCLC
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C8
- Not for CME Credit
- Type: Mini Oral
- Track: Early Stage Non-small Cell Lung Cancer
- Moderators:Terufumi Kato, Devayani Niyogi
-
+
Session Moderator
12:00 - 12:00 | Presenter: Terufumi Kato
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Devayani Niyogi
- Abstract
Loading... -
+
MA03.01 - Session Introduction
12:00 - 12:01 | Presenter: Terufumi Kato
- Abstract
Loading... -
+
MA03.02 - Session Introduction
12:01 - 12:02 | Presenter: Devayani Niyogi
- Abstract
Loading... -
+
MA03.03 - Predicting Occult Lymph Node Metastasis in Patients With Clinical Stage IA Non-small Cell Lung Cancer: A Prospective Cohort Study
12:02 - 12:07 | Presenter: Junghee Lee
- Abstract
Loading... -
+
MA03.04 - An Integrated Deep Learning Method to Predict Lung Cancer Recurrence Risk for Resected Stage IA NSCLC
12:07 - 12:12 | Presenter: Peng Huang
- Abstract
Loading... -
+
MA03.05 - EGFR mutation Is Not a Risk Factor for Postoperative Recurrence of Lung Adenocarcinoma on Long Follow-up of a Multi-Institutional Cohort
12:12 - 12:17 | Presenter: Yuki Matsumura
- Abstract
Loading... -
+
MA03.06 - Discussant
12:17 - 12:27 | Presenter: David Harpole
- Abstract
Loading... -
+
MA03.06 - Discussant
12:17 - 12:27 | Presenter: Betty Tong
- Abstract
Loading... -
+
MA03.07 - Accurate Intraoperative Diagnosis of Spread Through Air Spaces (STAS) Using a Cryo Embedding Medium Inflation Method
12:27 - 12:32 | Presenter: Takashi Eguchi
- Abstract
Loading... -
+
MA03.08 - Survival Impact of Benchmarking Lung Cancer Surgeons’ Performance by Quality Metrics
12:32 - 12:37 | Presenter: Meredith Ray
- Abstract
Loading... -
+
MA03.09 - Real-World Acute Toxicity and 90-day Mortality in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.
12:37 - 12:42 | Presenter: Nienke Wolfhagen
- Abstract
Loading... -
+
MA03.10 - Discussant
12:42 - 12:52 | Presenter: Young Tae Kim
- Abstract
Loading... -
+
MA03.11 - Live Q&A
12:52 - 13:00
- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-045 - Phase 1/2 Study of BLU-945 in Patients With Common Activating EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Elaine Shum- Abstract
Loading... -
+
EP08.02-108 - Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
Presenter: Marina Chiara Garassino- Abstract
Loading... -
+
EP08.02-113 - Clinico-genomic Characteristics of Patients with Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
Presenter: Masanobu Okahisa- Abstract
Loading... -
+
EP08.02-115 - A Retrospective, Multicenter, Observational Study to Evaluate Outcomes With Lorlatinib After Alectinib in ALK+ NSCLC in Japan
Presenter: Motohiro Tamiya- Abstract
Loading...
-
+
EP11.01 - Pathology - Genomics & Analytics
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Pathology - Genomics & Analytics
-
+
EP11.01-008 - Discrepancy in MET Exon 14 Skipping Mutation Measurement Between ArcherMET and Oncomine Dx Target Test System
Presenter: Kanako Shinada- Abstract
Loading...
-
+
OA12 - Novel and Combination Strategies for SCLC
- 16:00 - 17:00
- 8/08/2022
- Location: Hall C8
- Not for CME Credit
- Type: Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Alessandra Curioni-Fontecedro, Kostas Syrigos
-
+
OA12.06 - First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results
16:32 - 16:42 | Presenter: Charles M Rudin
- Abstract
Loading...
